Presidents


Paolo A. Ascierto

Paolo A. Ascierto
Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Tumori Fondazione Pascale, Naples, Italy



Francesco M. Marincola

Francesco M. Marincola
Chief Research Officer, Sidra Medical and Research Centre, Doha, Qatar




nicola mozzillo

Nicola Mozzillo
Director of the Department Melanoma and Soft Tissues, Istituto Tumori - Fondazione G. Pascale, Naples, Italy




scientific board

Paolo A. Ascierto

Paolo A. Ascierto
Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Tumori Fondazione Pascale, Naples, Italy



Paolo A. Ascierto

Lotfi Chouchane
Assistant Dean for Basic Science, Professor of Genetic Medicine, Professor of Microbiology & Immunology, Weill Cornell Medical College, Qatar



Gennaro Ciliberto


Gennaro Ciliberto
Scientific Director of the National Cancer Institute “Fondazione G. Pascale” of Naples, Italy



Bernard A. Fox


Bernard A. Fox       
Chief, Molecular and Tumor Immunology at Earle A. Chiles Research Institute, Portland, Oregon



Jérôme Galon


Claus Garbe
University Professor of Dermatology, Head, Division of Dermatologic Oncology Department of Dermatology Eberhard Karls University Tuebingen (Stuttgart), Germany



Francesco M. Marincola


John M. Kirkwood

Professor of Clinical and Translational Science, Clinical and Translational Science Institute, University of Pittsburgh, Pennsylvania



Alberto Mantovani

Alberto Mantovani
Scientific Director of Istituto Clinico Humanitas, Milan, Italy




Francesco M. Marincola


Francesco M. Marincola
Chief Research Officer, Sidra Medical and Research Centre, Doha, Qatar




nicola mozzillo


Giuseppe Masucci
Professor, Department of Oncology-Pathology, and KcRN, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden



nicola mozzillo


Ignacio Melero
Professor of Immunology and Consultant, CIMA, CUN and Medical School, University of Navarra, Pamplona, Spain



nicola mozzillo


Nicola Mozzillo
Director of the Department of Surgical Oncology B, National Cancer Institute of Naples, Italy



nicola mozzillo


Giuseppe Palmieri
Unit of Cancer Genetics, Institute of Biomolecular Chemistry, National Research Council, Sassari, Italy



Antoni Ribas

Antoni Ribas
Professor of Medicine, Surgery, and Molecular  and Medical Pharmacology at the University of California Los Angeles



David Stroncek

David Stroncek
Chief, Cell Processing Section, Department of Transfusion Medicine, NIH Clinical Center, Bethesda, Maryland



magdalena-thurin

Magdalena Thurin
Program Director, Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, NCI, NIH, Rockville, Maryland



Giorgio Trinchieri

Walter Urba
Director of Cancer Research, Earle A. Chiles Research Institute, Providence Cancer Center, Oregon



Fernando-Vidal-Vanaclocha

Fernando Vidal-Vanaclocha
Professor of Cell Biology and Human Histology, Vice Dean for Research and International Affairs and Scientific Director of the Institute of Applied Molecular Medicine (IMMA) at the CEU-San Pablo University School of Medicine, Madrid, Spain




Ena Wang
Acting Section Head of Infectious Disease and Immunogenetics Section (IDIS); Director of Molecular Science, Department of Transfusion Medicine, CC; Associated director of Center for Human Immunology, NIH, Maryland








 


For information please contact info@melanomabridge.org